Seattle Genetics, Inc.
21823 - 30th Drive S.E.
About Seattle Genetics, Inc.
Committed to improving patient outcomes
At Seattle Genetics, we are committed to developing innovative antibody-based therapies that improve clinical outcomes for patients with cancer and autoimmune diseases. We are dedicated to addressing unmet medical need, and strive to achieve that goal through an unwavering commitment to excellence in clinical development.
Focusing on Clinical Development
Seattle Genetics is a clinical stage biotechnology company advancing a broad product pipeline of antibody-based therapies. Our lead program, brentuximab vedotin (SGN-35), is in a pivotal trial under a Special Protocol Assessment with the FDA for patients with relapsed or refractory Hodgkin lymphoma. Brentuximab vedotin is empowered by Seattle Genetics' proprietary antibody-drug conjugate (ADC) technology. In addition, we are conducting clinical trials with four other product candidates, lintuzumab (SGN-33), dacetuzumab (SGN-40) and SGN-75, for the treatment of cancer, and SGN-70, for autoimmune diseases. We are also advancing a pipeline of promising preclinical candidates and have robust research and development capabilities that are our engine for innovation and long-term growth.
Our proprietary ADC technology empowers antibodies by stably linking them to cell-killing drug payloads. The drug payload is inactive until released from the antibody inside the targeted cancer cell, thereby sparing normal tissue the toxicity of traditional chemotherapy. In addition to brentuximab vedotin, SGN-75 is an ADC that is in a phase I clinical trial and we are developing several preclinical ADC product candidates, including ASG-5ME, which is advancing towards a planned 2010 clinical trial for solid tumors.
Expanding Our Opportunities Through Collaboration
Collaborating with leading biopharmaceutical companies is a cornerstone of Seattle Genetics' business strategy. Product-focused collaborations, such as our exclusive worldwide collaboration agreement with Genentech (a wholly owned member of the Roche Group) to develop and commercialize dacetuzumab, provide significant near- and mid-term funding while bringing in additional resources and expertise to support, advance and expand promising development programs. Collaboration and license agreements around our proprietary ADC technology also generate cash for the company - more than $75 million to date - while providing further clinical validation of the ADC platform and, in some cases, opening the door to new product development opportunities.
13 jobs with Seattle Genetics, Inc.
Summary: We are seeking a highly motivated individual to join our Potency Assay development team in a full-time position. The Potency Assay developme
Summary:Seattle Genetics is looking for a motivated Research Associate II to work in Potency and Impurity Assays group. The primary responsibility is
Summary: Seattle Genetics is seeking a proven senior leader to head the company's Quality organization for Antibody Drug Conjugates, Antibodies, small
Summary: The Sr. Safety Scientist will report to the Head of Safety Surveillance and Epidemiology in Drug Safety and Pharmacovigilance and will be pri
Summary: This position is for Medical Director/Senior Medical Director within the ENFORTUMAB VEDOTIN Genitourinary program. This position will be resp
Summary: Seattle Genetics is seeking a highly motivated Project Manager who will be responsible for managing and coordinating the late stage research
Summary: The Regulatory Affairs Specialist supports a senior regulatory professional by executing against the global regulatory plan for one or more p
Summary: Seattle Genetics is seeking a Research Associate to participate in the development of drug programs in a high-throughput core lab. Responsibi
Summary:The BioProcess Development Department at Seattle Genetics is seeking an upper level Research Associate to execute and lead purification proces
Summary: We are seeking innovative and motivated research associates to be on the forefront of studying novel antibody-drug conjugates and other thera
Summary: The BioProcess Development Department at Seattle Genetics is seeking a Research Associate to participate in the purification development effo
Summary:Seattle Genetics is looking for a motivated Sr. Research Associate to work in Potency and Impurity Assays group. The successful candidate will
Summary:The Analytical Sciences group at Seattle Genetics is seeking an experienced and highly motivated research associate to support development of